Fibrinogen alpha chain Antibody#69708,Cell Signaling Technology (CST),69708

Fibrinogen alpha chain Antibody recognizes endogenous levels of total fibrinogen alpha chain protein.

Reactivity

Human, Mouse, Rat

Application

Western Blotting: 1:1000 Immunoprecipitation: 1:50

Platform ID

BAB164476629

Cell Signaling Technology (CST)

Headquarters

3 Trask Lane Danvers, MA 01923

Contact

Tel: 877-616-2355,978-867-2388
Fax: 877-616-2355

Product Specifications
Scientific Background
Synonyms

Specifications

NameFibrinogen alpha chain Antibody#69708
Cat. No.69708
Accession NumberP02671
Gene ID (Entrez)02671, 2243
SensitivityEndogenous
ReactivityHuman, Mouse, Rat
ApplicationWestern Blotting: 1:1000 Immunoprecipitation: 1:50
Molecular Weight70, 100
FormulationSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C.Do not aliquot the antibody.
StorageSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C.Do not aliquot the antibody.
Regulatory StatusResearch Use Only

Scientific Background

Fibrinogen is a large, multimeric plasma glycoprotein that is constitutively synthesized by liver hepatocytes. As a key component of blood clots, fibrinogen plays a central role in hemostasis and thrombosis. In total, six polypeptide chains (2Aα, 2Bβ, and 2γ) are produced intracellularly in a coordinated manner, which are then covalently linked together by a network of disulfide bonds to form a fibrinogen heterohexamer (1). Research studies have shown that expression of the three fibrinogen genes is upregulated as part of the acute phase inflammatory response (2,3).Upon engagement of the clotting cascade, thrombin-mediated cleavage of the fibrinogen Aα and Bβ chains creates fibrin monomers and a platform for the polymerization of fibrin monomers into protofibrils and an insoluble web of stable fibrin fibers (4,5). Whereas thrombin is the enzyme that drives fibrin polymerization and clot formation, plasmin is the enzymatic counterpart that facilitates fibrinolysis and clot breakdown (6).In addition to its position as a central node in the normal coagulation cascade, dysregulated fibrin deposition has been observed in pathological conditions such as cancer and viral infection (7,8).Chapin, J.C. and Hajjar, K.A. (2015)Blood Rev29, 17-24.Dalmon, J. et al. (1993)Mol Cell Biol13, 1183-93.Huber, P. et al. (1990)J Biol Chem265, 5695-701.Lord, S.T. (2011)Arterioscler Thromb Vasc Biol31, 494-9.Yang, Z. et al. (2000)Proc Natl Acad Sci U S A97, 14156-61.Cesarman-Maus, G. and Hajjar, K.A. (2005)Br J Haematol129, 307-21.Fernandez, P.M. et al. (2004)Semin Thromb Hemost30, 31-44.Merad, M. and Martin, J.C. (2020)Nat Rev Immunol20, 355-362.Alternate NamesFGA; Fib2; FIBA; Fibrinogen; Fibrinogen alpha chain; fibrinogen, A alpha polypeptide; fibrinogen, alpha chain, isoform alpha preproprotein; fibrinogen, alpha polypeptide; Fibrinopeptide A; MGC119422; MGC119423; MGC119425

Synonyms

FGA; Fib2; FIBA; Fibrinogen; Fibrinogen alpha chain; fibrinogen, A alpha polypeptide; fibrinogen, alpha chain, isoform alpha preproprotein; fibrinogen, alpha polypeptide; Fibrinopeptide A; MGC119422; MGC119423; MGC119425

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.